Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Multi-drug resistant Mycobacterium tuberculosis complex genetic diversity and clues on recent transmission in Punjab, Pakistan.

Yasmin M, Gomgnimbou MK, Siddiqui RT, Refrégier G, Sola C.

Infect Genet Evol. 2014 Oct;27:6-14. doi: 10.1016/j.meegid.2014.06.017. Epub 2014 Jun 27.

PMID:
24981519
2.

Genetic diversity and molecular epidemiology of multidrug-resistant Mycobacterium tuberculosis in Minas Gerais State, Brazil.

Dantas NG, Suffys PN, Carvalho Wda S, Gomes HM, de Almeida IN, de Assis LJ, Augusto CJ, Gomgnimbou MK, Refregier G, Sola C, de Miranda SS.

BMC Infect Dis. 2015 Aug 1;15:306. doi: 10.1186/s12879-015-1057-y.

3.

Genotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China.

Yuan X, Zhang T, Kawakami K, Zhu J, Zheng W, Li H, Deng G, Tu S, Liu W.

BMC Infect Dis. 2013 Jul 12;13:315. doi: 10.1186/1471-2334-13-315.

4.

Spoligotype-based comparative population structure analysis of multidrug-resistant and isoniazid-monoresistant Mycobacterium tuberculosis complex clinical isolates in Poland.

Jagielski T, Augustynowicz-Kopec E, Zozio T, Rastogi N, Zwolska Z.

J Clin Microbiol. 2010 Nov;48(11):3899-909. doi: 10.1128/JCM.00572-10. Epub 2010 Sep 1.

5.

Correlations between drug resistance of Beijing/W lineage clinical isolates of Mycobacterium tuberculosis and sublineages: a 2009-2013 prospective study in Xinjiang province, China.

Wang XH, Ma AG, Han XX, Gu XM, Fu LP, Li PG, Li FY, Wang QZ, Liang H, Katar A, Wang LJ.

Med Sci Monit. 2015 May 7;21:1313-8. doi: 10.12659/MSM.892951.

6.

Multidrug-resistant tuberculosis in Lisbon, Portugal: a molecular epidemiological perspective.

Perdigão J, Macedo R, João I, Fernandes E, Brum L, Portugal I.

Microb Drug Resist. 2008 Jun;14(2):133-43. doi: 10.1089/mdr.2008.0798.

PMID:
18573039
7.

Genotyping and molecular characteristics of multidrug-resistant Mycobacterium tuberculosis isolates from China.

Zhang Z, Lu J, Liu M, Wang Y, Qu G, Li H, Wang J, Pang Y, Liu C, Zhao Y.

J Infect. 2015 Apr;70(4):335-45. doi: 10.1016/j.jinf.2014.11.008. Epub 2014 Dec 5.

PMID:
25485999
8.

Molecular epidemiology and clinical characteristics of drug-resistant Mycobacterium tuberculosis in a tuberculosis referral hospital in China.

Wang Q, Lau SK, Liu F, Zhao Y, Li HM, Li BX, Hu YL, Woo PC, Liu CH.

PLoS One. 2014 Oct 10;9(10):e110209. doi: 10.1371/journal.pone.0110209. eCollection 2014.

9.

Tuberculosis-spoligo-rifampin-isoniazid typing: an all-in-one assay technique for surveillance and control of multidrug-resistant tuberculosis on Luminex devices.

Gomgnimbou MK, Hernández-Neuta I, Panaiotov S, Bachiyska E, Palomino JC, Martin A, del Portillo P, Refregier G, Sola C.

J Clin Microbiol. 2013 Nov;51(11):3527-34. doi: 10.1128/JCM.01523-13. Epub 2013 Aug 21.

10.

Characterizing Mycobacterium tuberculosis isolates from Karachi, Pakistan: drug resistance and genotypes.

Ayaz A, Hasan Z, Jafri S, Inayat R, Mangi R, Channa AA, Malik FR, Ali A, Rafiq Y, Hasan R.

Int J Infect Dis. 2012 Apr;16(4):e303-9. doi: 10.1016/j.ijid.2011.12.015. Epub 2012 Feb 23.

11.

Genotypes and drug susceptibility of Mycobacterium tuberculosis Isolates in Shihezi, Xinjiang Province, China.

Zhang J, Mi L, Wang Y, Liu P, Liang H, Huang Y, Lv B, Yuan L.

BMC Res Notes. 2012 Jun 19;5:309. doi: 10.1186/1756-0500-5-309.

12.

Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.

Cho E, Shamputa IC, Kwak HK, Lee J, Lee M, Hwang S, Jeon D, Kim CT, Cho S, Via LE, Barry CE 3rd, Lee JS.

BMC Infect Dis. 2013 Oct 15;13:478. doi: 10.1186/1471-2334-13-478.

13.

Molecular epidemiology study of Mycobacterium tuberculosis and its susceptibility to anti-tuberculosis drugs in Indonesia.

Lisdawati V, Puspandari N, Rif'ati L, Soekarno T, M M, K S, Ratnasari L, Izzatun N, Parwati I.

BMC Infect Dis. 2015 Aug 22;15:366. doi: 10.1186/s12879-015-1101-y.

14.

Genotyping and drug resistance patterns of M. tuberculosis strains in Pakistan.

Tanveer M, Hasan Z, Siddiqui AR, Ali A, Kanji A, Ghebremicheal S, Hasan R.

BMC Infect Dis. 2008 Dec 24;8:171. doi: 10.1186/1471-2334-8-171.

16.

[Tuberculosis Laboratory Surveillance Network (TuLSA) study group. The first step for national tuberculosis laboratory surveillance: Ankara, 2011].

Sezen F, Albayrak N, Özkara Ş, Karagöz A, Alp A, Duyar Ağca F, İnan Süer A, Müderris T, Ceyhan İ, Durmaz R, Ertek M; Tüberküloz Laboratuvar Sürveyans Ağı Tulsa Çalışma Grubu, Tulsa.

Mikrobiyol Bul. 2015 Apr;49(2):143-55. Turkish.

17.

Mycobacterium tuberculosis Beijing lineage favors the spread of multidrug-resistant tuberculosis in the Republic of Georgia.

Niemann S, Diel R, Khechinashvili G, Gegia M, Mdivani N, Tang YW.

J Clin Microbiol. 2010 Oct;48(10):3544-50. doi: 10.1128/JCM.00715-10. Epub 2010 Aug 11.

18.

The population structure of drug-resistant Mycobacterium tuberculosis clinical isolates from Sichuan in China.

Zhao Y, Feng Q, Tang K, Zhang C, Sun H, Luo T, Yang Z, Couvin D, Rastogi N, Sun Q.

Infect Genet Evol. 2012 Jun;12(4):718-24. doi: 10.1016/j.meegid.2011.09.022. Epub 2011 Oct 2.

PMID:
21989209
19.

Molecular characterization and second-line antituberculosis drug resistance patterns of multidrug-resistant Mycobacterium tuberculosis isolates from the northern region of South Africa.

Said HM, Kock MM, Ismail NA, Mphahlele M, Baba K, Omar SV, Osman AG, Hoosen AA, Ehlers MM.

J Clin Microbiol. 2012 Sep;50(9):2857-62. doi: 10.1128/JCM.00358-12. Epub 2012 May 30.

20.

[Population structure analysis of Mycobacterium tuberculosis Beijing family in Japan].

Iwamoto T.

Kekkaku. 2009 Dec;84(12):755-9. Japanese.

PMID:
20077859
Items per page

Supplemental Content

Write to the Help Desk